Diabetes, Gestational: Clinical Trials

19 trials for Diabetes, Gestational, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

19 completed. 19 Phase 3, 5 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 319Completed 19
Phase 25Completed 5

Follow Diabetes, Gestational: new trials by email Literature Review of Diabetes, Gestational trials Research Report on Diabetes, Gestational

Trials (filtered) newest first · largest first

All 19 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Inhaled Insulin vs Rapid-acting Injections for Post-meal Glucose Control in Women With Gestational Diabetes
Inhaled Technosphere Insulin - Diabetes, Gestational, Pregnancy Complications
Phase 2 / Phase 3CompletedJaeb Center for Health Research302025-06-022026-10-19
A Pragmatic Approach to Lower Diabetes Risk After Gestational Diabetes
Metformin - Diabetes, Gestational, PreDiabetes
Phase 3CompletedTufts Medical Center202022-06-012025-04-20
Gestational Treatment With Ursodeoxycholic Acid Compared to Placebo to Reduce Severity of Gestational Diabetes Mellitus Diagnosed at 24-28 Weeks' Gestation
500 mg of ursodeoxycholic acid (UDCA), 500 mg of Placebo - Gestational Diabetes
Phase 3CompletedFundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia1132021-03-032023-11-14
Empagliflozin and the Preservation of Beta-cell Function in Women with Recent Gestational Diabetes
Empagliflozin 10 MG, Placebo oral capsule - Gestational Diabetes
Phase 3CompletedMount Sinai Hospital, Canada912018-07-012025-03-07
Maternal Weight Gain in Gestational Diabetes Controlled by Metformin Versus Insulin
Insulin, Metformin, Assessment of weight gain - Gestational Diabetes
Phase 3CompletedAin Shams University1242018-02-012019-02-15
RCT Metformin for Reduction of Gestational Diabetes Mellitus Effects
Metformin Hydrochloride, Placebo - Gestational Diabetes
Phase 3CompletedNational University of Ireland, Galway, Ireland5352017-06-062025-03-17
Dextrose Gel Does Not Prevent Neonatal Hypoglycemia
40% Dextrose gel - Hypoglycemia, Infant, Small for Gestational Age
Phase 2 / Phase 3CompletedBaylor College of Medicine2362016-07-012025-01-08
Comparison of Metformin and Insulin for Management of Gestational Diabetes Mellitus
Metformin, Insulin - Gestational Diabetes Mellitus in Pregnancy
Phase 3CompletedServices Institute of Medical Sciences, Pakistan2782016-02-012017-10-27
Medico-GDM Trial - Metformine to Prevent Gestational Diabetes Mellitus
Metformin, control diet - Gestational Diabetes Mellitus
Phase 3CompletedMaasstad Hospital4002014-10-082026-10-09
A Feasibility Study Looking at the Use of Glibenclamide and metfoRmin Versus stAndard Care in gEstational diabeteS
Glibenclamide, Insulin - Pregnancy, Gestational Diabetes
Phase 3CompletedUniversity of Edinburgh232014-07-012016-12-08
Multicenter Randomized Trial of Non-inferiority Between Glyburide and Insulin for the Treatment of Gestational Diabetes
Insulin, Glyburide - Diabetes, Gestational
Phase 3CompletedAssistance Publique - Hôpitaux de Paris9142012-05-182025-09-05
MAIN STUDY: Low Glycaemic Index (GI) Diet in the Management of GDM SUB-STUDY: The Breast Milk Sub-Study
Standard Care, Low GI diet - Gestational Diabetes Mellitus
Phase 2 / Phase 3CompletedUniversity of Toronto992011-10-012016-05-20
Combined Liraglutide and Metformin Therapy in Women With Previous Gestational Diabetes Mellitus (GDM)
Metformin XR plus placebo, Metformin XR plus liraglutide - Gestational Diabetes Mellitus, Type 2 Diabetes Mellitus
Phase 3CompletedWoman's1532011-08-112019-07-26
Metformin in Obese Non-diabetic Pregnant Women
Metformin, Placebo - Pregnancy Complications, Obesity
Phase 2 / Phase 3CompletedEpsom and St Helier University Hospitals NHS Trust4502010-10-012016-01-22
Gestational Diabetes: Insulin or Oral Hypoglycemic Agents?
Insulin, Metformin, glyburide and insulin - Gestational Diabetes Mellitus
Phase 3CompletedUniversité de Sherbrooke732010-08-012018-05-03
Efficacy of Behavioral Therapy and Exercise in Gestational Diabetes Mellitus (GDM)
Behavioral therapy, Exercise, Behavioral therapy and exercise - Birth-weight
Phase 3CompletedUniversity of Turin, Italy2002009-07-012013-01-23
Metformin Versus Insulin in the Treatment of Gestational Diabetes Mellitus
Metformin, Insulin - Gestational Diabetes Mellitus
Phase 2 / Phase 3CompletedUniversity of Oulu972005-06-012010-03-16
The Effects of Metformin on Pregnancy and Miscarriage Rates in Polycystic Ovary Syndrome (PCOS)
metformin - Polycystic Ovary Syndrome, Miscarriage
Phase 3CompletedUniversity of Oulu3262002-08-012010-02-23
Safety and Efficacy of Insulin Aspart vs. Regular Human Insulin in Gestational Diabetes
human insulin, insulin NPH, insulin aspart - Diabetes, Gestational Diabetes
Phase 3CompletedNovo Nordisk A/S272000-04-012016-12-22

Narrower conditions

Diabetes Mellitus (4)  ·  Insulin Resistance (4)  ·  Pregnancy Complications (3)  ·  Diabetes Mellitus, Type 2 (2)  ·  Abortion, Spontaneous (1)  ·  Birth Weight (1)  ·  Fetal Growth Retardation (1)  ·  Fetal Macrosomia (1)  ·  Glucose Intolerance (1)  ·  Glucose Metabolism Disorders (1)  ·  Hyperglycemia (1)  ·  Hypoglycemia (1)  ·  Infertility (1)  ·  Metabolic Syndrome (1)

Broader conditions

Endocrine System Diseases (19)  ·  Female Urogenital Diseases and Pregnancy Complications (19)  ·  Metabolic Diseases (19)  ·  Nutritional and Metabolic Diseases (19)  ·  Urogenital Diseases (19)  ·  Glucose Metabolism Disorders (18)  ·  Pregnancy Complications (16)  ·  Diabetes Mellitus (15)  ·  Hyperinsulinism (5)  ·  Body Weight (3)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Signs and Symptoms (3)  ·  Adnexal Diseases (1)  ·  Birth Weight (1)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)

Interventions

Metformin (9)  ·  Insulin (7)  ·  Glyburide (3)  ·  Behavior Therapy (1)  ·  Exercise (1)  ·  Glycemic Index (1)  ·  Insulin Aspart (1)  ·  Insulin, Isophane (1)  ·  Isophane Insulin, Human (1)  ·  Liraglutide (1)  ·  Standard of Care (1)  ·  Ursodeoxycholic Acid (1)  ·  empagliflozin (1)

Sponsors

University of Oulu (2)  ·  Ain Shams University (1)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  Baylor College of Medicine (1)  ·  Epsom and St Helier University Hospitals NHS Trust (1)  ·  Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia (1)  ·  Jaeb Center for Health Research (1)  ·  Maasstad Hospital (1)  ·  Mount Sinai Hospital, Canada (1)  ·  National University of Ireland, Galway, Ireland (1)  ·  Novo Nordisk A/S (1)  ·  Services Institute of Medical Sciences, Pakistan (1)  ·  Tufts Medical Center (1)  ·  University of Edinburgh (1)  ·  University of Toronto (1)

Countries

United States (5)  ·  Canada (3)  ·  Finland (2)  ·  United Kingdom (2)  ·  Egypt (1)  ·  France (1)  ·  Ireland (1)  ·  Italy (1)  ·  Netherlands (1)  ·  Pakistan (1)  ·  Spain (1)

Top investigators

Amy Valent, DO (1)  ·  Dr Jyoti Balani, MD (1)  ·  Dr Ranjit Akolekar (1)  ·  Dr Steve Hyer, MD, FRCP (1)  ·  Erika Werner, MD (1)  ·  Hilkka Ijas, MD (1)  ·  Jane E Norman, MD (1)  ·  Jean-Luc Ardilouze, MD, PhD (1)  ·  Jeffrey R Kaiser, MD, MA, FAAP (1)  ·  Joke van der Linden, dr. (1)  ·  Karen E Elkind-Hirsch, Ph.D. (1)  ·  Laure C Morin-Papunen, PhD (1)

Results publications

PMID 12502678, PMID 17888133, PMID 21083860, PMID 23122829, PMID 25646328, PMID 26840133, PMID 28938877, PMID 29605395, PMID 29715355, PMID 31227287, PMID 32046931, PMID 36131291, PMID 37786390, PMID 39215812, PMID 40964955

NIH funding

2008 (1), 2014 (1)